[1] | Ana L. Flores-Mireles AL, Walker JN, Caparon M & Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology. 2015; 13(5): 269-284. |
|
[2] | Stamm, W. E., and Norrby, S. R. Urinary tract infections: disease panorama and challenges. J. Infect. Dis. 2001; 183(Suppl. 1), S1-S4. |
|
[3] | Medina, M; Castillo-Pino, E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 2019; 11: 1756287219832172. |
|
[4] | Nitzan O, Elias M, Chazan B, Walid. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015; 8: 129-136. |
|
[5] | Sewify M, Nair S, Warsame S, Murad M, Alhubail A, Behbehani K, Al-Refaei F, Tiss A. “Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait”. Journal of Diabetes Research.2016; Article ID 6573215, 7 pages, 2016. |
|
[6] | Erdem I, Ali RK, Ardic E, Omar SE, Mutlu R, and Topkaya AE. Community-acquired Lower Urinary Tract Infections: Etiology, Antimicrobial Resistance, and Treatment Results in Female Patients. J Glob Infect Dis. 2018; 10(3): 129-32. |
|
[7] | Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Fatemeh A , Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine. 2017; 96(37) 7834. |
|
[8] | Clinical and Laboratory Standards Institute® (CLSI). M 100 Performance Standards for Antimicrobial Susceptibility Testing, 30thedition. 2020. |
|
[9] | Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, and Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int J Health Sci (Qassim). 2019; 13(2): 48-55. |
|
[10] | Alamiri A, Hamid ME, Abid M, Alwahhabi KM, Algarni MS, Abomughaid M. Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia. Urol Ann. 2018; 10: 41-6. |
|
[11] | Bonkat G, Pilatz, A, Wagenlehner F. Time to adapt our practice? The European Commission has restricted the use of Fluoroquinolones since March 2019. Eur. Urol. 2019; 76: 273-275. |
|
[12] | Chibelean CB, Petca RC, Mareș C, Popescu R, Eniko B, Mehedințu C, Petca A. A Clinical Perspective on the Antimicrobial Resistance Spectrum of Uropathogens in a Romanian Male Population. Microorganisms. 2020; 8(6): 848. |
|
[13] | Folliero V, Caputo P, Della Rocca, M.T, Chianese, A, Galdiero M, Iovene M.R, Hay C, Franci G, Galdiero M. Prevalence and Antimicrobial Susceptibility Patterns of Bacterial Pathogens in Urinary Tract Infections in University Hospital of Campania “Luigi Vanvitelli” between 2017 and 2018. Antibiotics. 2020; 9: 215. |
|
[14] | Gupta K, Hooton T.M, Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 2001; 135: 41-50. |
|
[15] | Hrbacek J, Cermak P and Zachoval R. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011-2019. Antibiotics. 2020; 9(9): 630. |
|
[16] | Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. J Med Microbiol. 2017; 66(1): 61-69. |
|
[17] | Lu PL , Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, Huang CC, Liu CE, Ko WC, et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia- Pacific Region: 2009-2010 results from the study for monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents. 2012; 40 suppl: S 37-43. |
|
[18] | Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Paolo Romano P, and Cocuzza CE. Gender and Age-Dependent Etiology of Community-Acquired Urinary Tract Infections. The Scientific World Journal. 2012; (6): 349597. |
|
[19] | Tandogdu Z, Wagenlehner F M E. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016; 29(1): 73-9. |
|
[20] | Odoki M, Aliero AA, Tibyangye J, Maniga JN, Wampande E, Kato CD, Agwu E, and Bazira J Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda. International Journal of Microbiology. 2019. |Article ID 4246780. |
|
[21] | Sneka P and Mangayarkarasi V. Bacterial pathogens causing UTI and their antibiotic sensitivity pattern: a study from a tertiary care hospital from South India. Tropical Journal of Pathology and Microbiology. 2019; 5(6): 379-385. |
|
[22] | Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: A minireview. Journal of Infection and Public Health.2009; 2(3): 101-111. |
|
[23] | Saha S, Nayak S, Bhattacharyya I, Saha S, Mandal AK, Chakraborty S et al. Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India. Front. Microbiol. 2014. |
|
[24] | Saha AK. Pattern of antimicrobial susceptibility of Klebsiella pneumoniae isolated from urinary samples in urinary tract infection in a tertiary care hospital, Kishanganj, Bihar, 5 years’ experience. International Journal of Contemporary Medical Research. 2019; 6 (12): L25-L28. |
|
[25] | Prasada S, Bhat A, Bhat S, Mulki SS, Tulsidas S. Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infection and Drug Resistance. Dovepress. 2019; |
|
[26] | Mehrishi P, Faujdar SS, Kumar S, Solanki S, Sharma A. Antibiotic susceptibility profile of uropathogens in rural population of Himachal Pradesh, India: Where We are heading? Biomed Biotechnol Res J. 2019; 3: 171-5. |
|
[27] | Critchley IA, Cotroneo N, Pucci MJ, Mendes R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE. 2019; 14(12): e0220265. |
|
[28] | Haddad M. Antimicrobial Resistance of Uropathogens and Rationale for Empirical Therapy in Jordan. Biomed Pharmacol J. 2014; 7(1). |
|
[29] | Singh P, Malik S and Lal V. Resistance Pattern of Nitrofurantoin of Uropathogens in Different Age Groups at Dr. Lal Path Labs, National Reference Laboratory, Rohini, Delhi. Asian Journal of Medicine and Health. 2019; 16(1): 1-8, 2019; Article no.AJMAH.50908. |
|